Latest Medicxi Ventures Management (Jersey) Ltd Stock Portfolio
$177Million | No. of Holdings #3
Medicxi Ventures Management (Jersey) Ltd Performance
2026 Q2+2.06%
YTD+36.25%
2025+42.99%
About Medicxi Ventures Management (Jersey) Ltd and 13F Hedge Fund Stock Holdings
On 2026-08-04, the fund reported it's updated stock portfolio. In the 13F Holdings report, Medicxi Ventures Management (Jersey) Ltd reported an equity portfolio of $177.4 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Medicxi Ventures Management (Jersey) Ltd are PHAT, NAMS, AURA. The fund has invested 45.6% of it's portfolio in PHATHOM PHARMACEUTICALS INC and 42.2% of portfolio in NEWAMSTERDAM PHARMA COMPANY. <br><br> The fund managers got completely rid off CENTESSA PHARMACEUTICALS PLC (CNTA) stocks. They significantly reduced their stock positions in NEWAMSTERDAM PHARMA COMPANY (NAMS).
Medicxi Ventures Management (Jersey) Ltd Equity Portfolio Value
Last Reported on: 04 Aug, 2026
$177Million
as of Aug 04, 2026Medicxi Ventures Management (Jersey) Ltd Annual Return Estimates Vs S&P 500
Our best estimate is that Medicxi Ventures Management (Jersey) Ltd made a return of 2.06% in the last quarter. In trailing 12 months, it's portfolio return was 138.54%.
- Performance
- S&P 500
New Buys
No new stocks were added by Medicxi Ventures Management (Jersey) Ltd
Additions
No additions were made to existing positions by Medicxi Ventures Management (Jersey) Ltd
Reductions
| Ticker | % Reduced |
|---|---|
| newamsterdam pharma company | -17.41 |
Medicxi Ventures Management (Jersey) Ltd reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| centessa pharmaceuticals plc | -792,937,000 |
Medicxi Ventures Management (Jersey) Ltd got rid off the above stocks
Sector Distribution
Medicxi Ventures Management (Jersey) Ltd has about 57.8% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 57.8 |
| Others | 42.2 |
Market Cap. Distribution
Medicxi Ventures Management (Jersey) Ltd has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- SMALL-CAP
- UNALLOCATED
| Category | % |
|---|---|
| SMALL-CAP | 57.8 |
| UNALLOCATED | 42.2 |
Stocks belong to which Index?
About 57.8% of the stocks held by Medicxi Ventures Management (Jersey) Ltd either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 57.8 |
| Others | 42.2 |
Medicxi Ventures Management (Jersey) Ltd Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Medicxi Ventures Management (Jersey) Ltd
Medicxi Ventures Management (Jersey) Ltd has 3 stocks in it's portfolio. PHAT proved to be the most loss making stock for the portfolio. NAMS was the most profitable stock for Medicxi Ventures Management (Jersey) Ltd last quarter.
$177.42MTotal Value
4.00Positions
04 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Aura Biosciences Inc Medicxi Ventures Management (Jersey) Ltd's holding in Aura Biosciences Inc over time | 12.16% | 3,039,890 | $21.58M 12.16% | 0%unchanged 0 percentunchanged | |
 Centessa Pharmaceuticals Plc Medicxi Ventures Management (Jersey) Ltd's holding in Centessa Pharmaceuticals Plc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 NAMS Newamsterdam Pharma CompanyNewamsterdam Pharma CompanyNAMS | 42.19% | 2,208,640 | $74.85M 42.19% | 17.41%decreased 17.41 percentreduced | |
 Phathom Pharmaceuticals Inc Medicxi Ventures Management (Jersey) Ltd's holding in Phathom Pharmaceuticals Inc over time | 45.65% | 7,464,570 | $80.99M 45.65% | 0%unchanged 0 percentunchanged | |